Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease

Copyright © 2019 Lei Wei et al.

Bibliographische Detailangaben
Veröffentlicht in:Neural plasticity. - 1998. - 2019(2019) vom: 24., Seite 1247276
1. Verfasser: Wei, Lei (VerfasserIn)
Weitere Verfasser: Chen, Chuan, Ding, Li, Mo, Mingshu, Zou, Jing, Lu, Zhenze, Li, Haiyan, Wu, Haotian, Dai, Yongqiang, Xu, Pingyi, Lu, Zhengqi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2019
Zugriff auf das übergeordnete Werk:Neural plasticity
Schlagworte:Journal Article Research Support, Non-U.S. Gov't CTNNB1 protein, human Excitatory Amino Acid Transporter 2 Wnt1 Protein beta Catenin Glutamic Acid 3KX376GY7L Oxidopamine 8HW4YBZ748
LEADER 01000naa a22002652 4500
001 NLM301901856
003 DE-627
005 20231225105604.0
007 cr uuu---uuuuu
008 231225s2019 xx |||||o 00| ||eng c
024 7 |a 10.1155/2019/1247276  |2 doi 
028 5 2 |a pubmed24n1006.xml 
035 |a (DE-627)NLM301901856 
035 |a (NLM)31582965 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Wei, Lei  |e verfasserin  |4 aut 
245 1 0 |a Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease 
264 1 |c 2019 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 27.07.2020 
500 |a Date Revised 27.07.2020 
500 |a published: Electronic-eCollection 
500 |a Citation Status MEDLINE 
520 |a Copyright © 2019 Lei Wei et al. 
520 |a Background: Wnt/β-catenin signaling has been reported to exert cytoprotective effects in a cellular model of Parkinson's disease (PD). Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of PD, and excitatory amino acid transporters (EAATs) play a predominant role in clearing excessive glutamate. EAAT2 is mainly expressed in astrocytes, which are an important source of Wnt signaling in the brain 
520 |a Methods: Wnt1-overexpressing U251 astrocytes were indirectly cocultured with dopaminergic SH-SY5Y cells treated with 6-hydroxydopamine (6-OHDA). Cell toxicity was determined by cell viability and flow cytometric detection. Glutamate level in the culture medium was determined by enzyme-linked immunosorbent assay (ELISA). Western blot analysis was used to detect the expression of Wnt1, β-catenin, and EAAT2. Immunofluorescence was used to display the expression and translocation of NF-κB p65 
520 |a Results: 6-OHDA treatment significantly decreased cell viability in both U251 cells and SH-SY5Y cells, inhibited the expression of Wnt1, β-catenin, and EAAT2 in U251 cells, and increased the glutamate level in the culture medium. Coculture with Wnt1-overexpressing U251 cells attenuated 6-OHDA-induced apoptosis in SH-SY5Y cells. Overexpression of Wnt1 decreased the glutamate level in the culture media, upregulated β-catenin, EAAT2, and NF-κB levels, and promoted the translocation of NF-κB from the cytoplasm to the nucleus in U251 cells 
520 |a Conclusion: Wnt1 promoted EAAT2 expression and mediated the cytoprotective effects of astrocytes on dopaminergic cells. NF-κB might be involved in the regulation of EAAT2 by Wnt1 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a CTNNB1 protein, human  |2 NLM 
650 7 |a Excitatory Amino Acid Transporter 2  |2 NLM 
650 7 |a Wnt1 Protein  |2 NLM 
650 7 |a beta Catenin  |2 NLM 
650 7 |a Glutamic Acid  |2 NLM 
650 7 |a 3KX376GY7L  |2 NLM 
650 7 |a Oxidopamine  |2 NLM 
650 7 |a 8HW4YBZ748  |2 NLM 
700 1 |a Chen, Chuan  |e verfasserin  |4 aut 
700 1 |a Ding, Li  |e verfasserin  |4 aut 
700 1 |a Mo, Mingshu  |e verfasserin  |4 aut 
700 1 |a Zou, Jing  |e verfasserin  |4 aut 
700 1 |a Lu, Zhenze  |e verfasserin  |4 aut 
700 1 |a Li, Haiyan  |e verfasserin  |4 aut 
700 1 |a Wu, Haotian  |e verfasserin  |4 aut 
700 1 |a Dai, Yongqiang  |e verfasserin  |4 aut 
700 1 |a Xu, Pingyi  |e verfasserin  |4 aut 
700 1 |a Lu, Zhengqi  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Neural plasticity  |d 1998  |g 2019(2019) vom: 24., Seite 1247276  |w (DE-627)NLM098558390  |x 1687-5443  |7 nnns 
773 1 8 |g volume:2019  |g year:2019  |g day:24  |g pages:1247276 
856 4 0 |u http://dx.doi.org/10.1155/2019/1247276  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_21 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 2019  |j 2019  |b 24  |h 1247276